Iterum Therapeutics plc Quarterly Debt-to-equity in % from Q1 2019 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Iterum Therapeutics plc quarterly Debt-to-equity history and growth rate from Q1 2019 to Q2 2024.
  • Iterum Therapeutics plc Debt-to-equity for the quarter ending June 30, 2024 was -598 %, a 422% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -598 -784 -422% Jun 30, 2024
Q1 2024 -6.96K -7.08K -5832% Mar 31, 2024
Q4 2023 658 +562 +589% Dec 31, 2023
Q3 2023 275 +190 +225% Sep 30, 2023
Q2 2023 186 +106 +133% Jun 30, 2023
Q1 2023 121 +30 +32.8% Mar 31, 2023
Q4 2022 95.4 -31.2 -24.7% Dec 31, 2022
Q3 2022 84.7 -253 -74.9% Sep 30, 2022
Q2 2022 79.7 +1.19K Jun 30, 2022
Q1 2022 91.4 +358 Mar 31, 2022
Q4 2021 127 +294 Dec 31, 2021
Q3 2021 337 +510 Sep 30, 2021
Q2 2021 -1.11K -884 -392% Jun 30, 2021
Q1 2021 -266 +243 +47.7% Mar 31, 2021
Q4 2020 -168 -573 -141% Dec 31, 2020
Q3 2020 -173 -287 -252% Sep 30, 2020
Q2 2020 -226 -281 -510% Jun 30, 2020
Q1 2020 -509 -543 -1608% Mar 31, 2020
Q4 2019 406 Dec 31, 2019
Q3 2019 114 Sep 30, 2019
Q2 2019 55.1 Jun 30, 2019
Q1 2019 33.8 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.